series-c-plus
Stage
1
Investors
About
CORXEL Pharmaceuticals is a biopharmaceutical company developing therapies targeting cardiometabolic and cardiovascular diseases, including hypertrophic cardiomyopathy and heart failure, with operations in the US and China.
Explore CORXEL Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.